Singapore Radiation Oncology Market Size & Outlook
Singapore radiation oncology market, 2017-2028 (US$M)
Related Markets
Singapore radiation oncology market highlights
- The Singapore radiation oncology market generated a revenue of USD 81.8 million in 2020 and is expected to reach USD 147.0 million by 2028.
- The Singapore market is expected to grow at a CAGR of 7.6% from 2021 to 2028.
- In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
- Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
Radiation oncology market data book summary
| Market revenue in 2020 | USD 81.8 million |
| Market revenue in 2028 | USD 147.0 million |
| Growth rate | 7.6% (CAGR from 2020 to 2028) |
| Largest segment | External beam radiationtherapy |
| Fastest growing segment | Internal Beam Radiation Therapy |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
Other key industry trends
- In terms of revenue, Singapore accounted for 1.1% of the global radiation oncology market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Asia Pacific, China radiation oncology market is projected to lead the regional market in terms of revenue in 2028.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 532.9 million by 2028.
External beam radiationtherapy was the largest segment with a revenue share of 80.32% in 2020. Horizon Databook has segmented the Singapore radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
Singapore had an age-standardized cancer rate of 248.9 per 100,000 people in 2018. The incidence of cancer reported in Singapore was 26,164 in 2018. Colorectal cancer is the most common type, followed by prostate cancer. Radiation therapy is in high demand as many patients are not suitable for surgery.
Radiotherapy techniques such as Intensity Modulated Radiotherapy (IMRT) can be used in the treatment of lung cancer for patients that cannot opt for surgery. Singapore has a limited number of radiology centers to cater to its population and the government plans to expand radio services for its aging population.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiation Oncology Market Scope
Radiation Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Singapore radiation oncology market size, by type, 2017-2028 (US$M)
Singapore Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
